MR imaging of transverse myelitis using Gd-DTPA.

MR imaging of transverse myelitis using Gd-DTPA. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

MR imaging of transverse myelitis using Gd-DTPA. Abstract Text:

K Pardatscher,D L Fiore,A Lavano,

A patient with subacute transverse myelitis (TM) had MRI studies, including scans after Gd-DTPA administration. The enhancement, with its intensity and persistence, seems to herald residual cord deficits. TM remains a clinical diagnosis of exclusion whereas MRI plays a valuable role in the assessment of the different abnormalities which may produce this syndrome and also defines accurately the location and extent of the intramedullary pathology.

MR imaging of transverse myelitis using Gd-DTPA. Publishing Authors By Initials

K Pardatscher,DL Fiore,A Lavano,

For similar diagnosis: prognosis research abstracts see: diagnosis: prognosis research

PUBMED ID PMID:

MEDLINE DATE:

MR imaging of transverse myelitis using Gd-DTPA. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Journal of neuroradiology. Journal de neuroradiolo

VOLUME: 19

Page Numbers: 63-7

Journal Abbreviation:

ISSN: 0150-9861

DAY: 20

MONTH: 02

YEAR: 1992

MR imaging of transverse myelitis using Gd-DTPA. Information

Number of References:

LANGUAGE: fre

NlmUniqueID: 7705086

MR imaging of transverse myelitis using Gd-DTPA. Keywords Mesh Terms:

KEYWORDS: Prognosis

MESH TERMS: diagnostic use

Chemical & Substance for Abstract: MR imaging of transverse myelitis using Gd-DTPA. Information

Substance Name: Gadolinium DTPA

Registry Number: 80529-93-7

Grant and Affiliation Information for MR imaging of transverse myelitis using Gd-DTPA.

AFFILIATION: Cattedra di Neuroradiologia, Catanzaro, Italia.

Country: FRANCE

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Neuroradiol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

MR imaging of transverse myelitis using Gd-DTPA Related Publications

• MR imaging of transverse myelitis using Gd-DTPA.
• Relationship between high prolactine levels and migraine attacks in patients with microprolactinoma.